Hemo Organic Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September, 2026, following a Board meeting held on 17th October, 2026 from 4:00 PM to 6:30 PM.
Financial Performance (Quarter Ended 30th September, 2026)
- Total Income: ₹142.90 lakhs, comprising entirely of revenue from operations (₹142.90 lakhs)
- Total Expenses: ₹142.37 lakhs, including:
- Purchases of Stock-in-trade: ₹140.00 lakhs
- Employee benefit expense: ₹1.56 lakhs
- Finance costs: ₹0.01 lakhs
- Depreciation and amortization: ₹0.80 lakhs
- Profit Before Tax: ₹0.53 lakhs
- Tax Expense: ₹0.00 lakhs
- Profit After Tax: ₹0.53 lakhs
- Earnings Per Share (Basic & Diluted): ₹0.01
Comparative Performance
Quarter Comparison (30.09.2026 vs 30.09.2025):
- Revenue increased from ₹0.01 lakhs to ₹142.90 lakhs
- Profit turned positive from loss of ₹3.09 lakhs to profit of ₹0.53 lakhs
- EPS improved from negative ₹0.09 to positive ₹0.01
Half Year Comparison (30.09.2026 vs 30.09.2025):
- Revenue: ₹142.90 lakhs vs ₹0.20 lakhs
- Profit: Negative ₹6.89 lakhs vs negative ₹11.66 lakhs
- EPS: Negative ₹0.19 vs negative ₹0.34
Capital Structure
- Paid-up Equity Share Capital: Increased to ₹686.59 lakhs (face value ₹10 each) from ₹346.59 lakhs as of 31st March, 2026
- Reserves/Other Equity: Negative ₹361.44 lakhs compared to negative ₹439.55 lakhs as of 31st March, 2026
Financial Position (as at 30th September, 2026)
- Total Assets: ₹475.80 lakhs
- Non-current Assets: ₹110.54 lakhs (including Property, Plant and Equipment: ₹0.27 lakhs)
- Current Assets: ₹365.26 lakhs (including Inventories: ₹77.07 lakhs, Cash and cash equivalents: ₹1.28 lakhs)
- Total Equity: ₹325.15 lakhs
- Total Liabilities: ₹150.65 lakhs
Cash Flow Statement (Half Year Ended 30th September, 2026)
- Net Cash from Operating Activities: Negative ₹182.72 lakhs
- Net Cash from Investing Activities: Positive ₹9.11 lakhs
- Net Cash from Financing Activities: Positive ₹173.80 lakhs (mainly from increase in equity share capital: ₹318.75 lakhs)
- Net Change in Cash: Positive ₹0.19 lakhs
- Closing Cash Balance: ₹1.28 lakhs
Auditor's Review
VSSB & Associates issued a limited review report with a qualified opinion stating: "We have not been provided with the balance confirmation or any other details for the trade receivable & trade payable in the books of accounts & in the absence of the same we are unable to confirm the balance and nature of the transactions."
Board Approval
The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting on 17th October, 2026.